Rating
Buy
Price target
$320
Previous
$235
Implied upside
+35%

BofA Securities analyst Vivek Arya upgraded Texas Instruments (NASDAQ: TXN) from Neutral to Buy with a price target of $320.00 (from $235.00).

“Texas Instruments’ (TXN) solid Q1 report and Q2 guide increases our confidence in TXN’s ability to: 1) Benefit from industrial resurgence, including in aero/defense ($1bn+ annual business), 2) Take advantage in data-center build (11% of sales, up 90% YoY), 3) Leverage the last 3 years of capex in US-fabs to potentially gain share in an “everythingis-constrained” chip environment.

Pricing has not been a factor, but could offer incremental good news in 2H which we conservatively model below seasonal trends.

Ongoing macro flux/geopolitics remains a sector-wide risk, but we think TXN has historically had a relatively more defensive profile, with improving FCF capability as it is past its big capex investment cycle.

Overall we raise CY26/27/28E GAAP EPS by 21%/31%/33% to $7.52/$9.35/$10.75, and now project FCF/sh to head towards $12/sh by CY28 from $8 in the current FY26E year.

Raise PO to $320 from $235 on 34x CY27 PE, slightly higher than 33x prior, on faster EPS growth (26% CY25-28 CAGR vs.14% prior).

We also see potential for catch-up in investor interest, given the stock’s considerable lag (100-200 percentage points) vs. the SOX over the last 1/3/5 years.”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on